Stock Price
193.20
Daily Change
4.90 2.60%
Monthly
7.81%
Yearly
-23.42%
Q3 Forecast
191.69

Peers Price Chg Day Year Date
Avita Medical 1.34 0.01 0.75% -48.46% Sep/05
Tectonic Therapeutic 16.80 -0.47 -2.72% -8.50% Sep/05
Ionis Pharmaceuticals 61.23 1.88 3.17% 30.58% Sep/05
IQVIA Holdings 187.68 3.60 1.96% -22.83% Sep/05
Dianthus Therapeutics 26.50 1.84 7.46% -0.45% Sep/05
Moderna 25.14 0.86 3.54% -65.54% Sep/05
Organon & Co 10.38 0.70 7.23% -49.40% Sep/05
Revvity 86.64 0.94 1.10% -24.90% Sep/05
Sartorius 193.20 4.90 2.60% -23.42% Sep/06
Viatris 10.50 0.17 1.65% -6.87% Sep/05
Xeris Pharmaceuticals 7.85 -0.04 -0.51% 212.75% Sep/05
Alaunos Therapeutics 2.16 0 0% -10.74% Sep/05

Indexes Price Day Year Date
DE40 23597 -173.35 -0.73% 28.93% Sep/05
EU600 549 -0.88 -0.16% 8.42% Sep/05

Sartorius traded at 193.20 this Saturday September 6th, increasing 4.90 or 2.60 percent since the previous trading session. Looking back, over the last four weeks, Sartorius gained 7.81 percent. Over the last 12 months, its price fell by 23.42 percent. Looking ahead, we forecast Sartorius to be priced at 191.69 by the end of this quarter and at 187.24 in one year, according to Trading Economics global macro models projections and analysts expectations.